Three Vanderbilt technologies earn US patent protection in March

Vanderbilt University was awarded three U.S. patents for intellectual property (IP) during the month of March. The technologies include new pharmaceutical tool compounds from the Vanderbilt Center for Neuroscience Drug Discovery; molecular intracellular transporters developed by a team of researchers from Chemistry, Pharmacology, Microbiology and Immunology, and Biochemistry; and a powered prosthetic leg developed in the Vanderbilt Center for Intellgient Mechatronics.

8,986,396      Powered leg prosthesis and control methodologies for obtaining near normal gait

8,969,622      Dendritic molecular intracellular transporters and methods of making and using same

8,969,389      Substituted 6-methylnicotinamides as mGluR5 positive allosteric modulators